Subcutaneously Administered CAMPATH in CD52 Expressing Hematologic Malignancies
This study has been terminated.
Sponsor:
Genzyme
Information provided by:
Genzyme
ClinicalTrials.gov Identifier:
NCT00113048
First received: June 3, 2005
Last updated: July 28, 2009
Last verified: December 2005
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Estimated Study Completion Date: | September 2005 |
| Estimated Primary Completion Date: | No date given |